Rebyota
Kathryn Dzintars, Pharm.D., BCPS
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Prevention
of recurrent
Clostridioides difficile infection (CDI)
in individuals 18 years of age and older,
following
antibiotic treatment for recurrent CDI
Rebyota is NOT indicated for the treatment of CDI.
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.